Korea S.E.
03:30:00 24/05/2024 am IST
5-day change
1st Jan Change
1,628
KRW
-1.99%
-2.81%
-24.28%
Cellumed Co., Ltd. announced that it has received KRW 13.91999 billion in funding from Free Telecom Co., Ltd. and other investors
On February 8, 2021, Cellumed Co., Ltd. (KOSDAQ:A049180) closed the transaction. The company has amended the terms of the transaction. The company issued 4,971,425 shares for gross proceeds of KRW 13,919,990,000. Morf Companion 11 Private Equity Partnership subscribed for 964,285 shares.
Cellumed Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
21/03
CI
Cellumed Co.,Ltd. announced that it has received KRW 10.000000362 billion in funding
07/03
CI
Cellumed Co.,Ltd. announced that it expects to receive KRW 10.000000362 billion in funding
29/02
CI
Cellumed Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
13/11
CI
Cellumed Co., Ltd. announced that it has received KRW 3 billion in funding
06/23/06
CI
Cellumed Co., Ltd. announced that it has received KRW 2 billion in funding
01/23/01
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 2 billion in funding
31/23/31
CI
Cellumed Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
14/23/14
CI
Cellumed Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/23/15
CI
Cellumed Co., Ltd. announced that it has received KRW 5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm
05/23/05
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Sangsangin Savings Bank, Investment Arm, Sangsangin Plus Savings Bank, Investment Arm
29/23/29
CI
Cellumed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
22/23/22
CI
Cellumed Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
14/22/14
CI
Cellumed Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
12/22/12
CI
Cellumed Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
16/22/16
CI
Cellumed Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
21/22/21
CI
Cellumed Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
15/21/15
CI
Cellumed Co., Ltd.(KOSDAQ:A049180) added to S&P Global BMI Index
20/21/20
CI
BH Cell Co., Ltd. announced that it has received KRW 7.5 billion in funding from Cellumed Co., Ltd. and other investors
31/21/31
CI
Cellumed Co., Ltd. announced that it has received KRW 15 billion in funding from High Value Life Science No. 1 Investment Association, BNS Investment Ltd
02/21/02
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 15 billion in funding from High Value Life Science No. 1 Investment Association, BNS Investment Ltd
14/21/14
CI
Cellumed Co., Ltd. acquired an additional 46.3% stake in Hwankyung ENG Co., Ltd. from Free Telecom Co., Ltd. for KRW 10 billion.
09/21/09
CI
Cellumed Co., Ltd. announced that it has received KRW 13.91999 billion in funding from Free Telecom Co., Ltd. and other investors
08/21/08
CI
Cellumed Co., Ltd. announced that it expects to receive KRW 24.2199888 billion in funding from Free Telecom Co., Ltd. and other investors
29/21/29
CI
Cellumed Co., Ltd. cancelled the acquisition of 97.3% stake in Hwankyung ENG Co., Ltd. for KRW 18 billion.
16/20/16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
CELLUMED CO., LTD., formerly Korea Bone Bank CO., LTD, is a Korea-based company engaged in the manufacture and sale of medical equipment and biosimilars. The Companyâs products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The Company sells its products within domestic market and to overseas markets.
More about the company
1st Jan change
Capi.
-24.28% 59.85M +12.05% 126B -9.24% 10.89B +0.29% 9.02B +36.99% 5.41B -21.98% 4.6B +8.02% 3.44B -10.32% 2.74B -12.33% 2.06B -13.53% 1.96B
Medical Devices & Implants
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
CELLUMED CO.,LTD. 
